Is Apellis a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Apellis Pharmaceuticals Inc (APLS) is (93.09) USD. With the latest stock price at 24.66 USD, the upside of Apellis Pharmaceuticals Inc based on DCF is -477.5%. This means that Apellis is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 9.1% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (239.99) - (59.41) | (93.09) |
| Upside | -1073.2% - -340.9% | -477.5% |